SK284027B6 - Process for the preparation of N-[5-(diphenylphosphinoylmethyl)- 4-(4-fluorphenyl)-6-isopropylpyrimidin-2-yl]-N- methylmethansulfonamide - Google Patents
Process for the preparation of N-[5-(diphenylphosphinoylmethyl)- 4-(4-fluorphenyl)-6-isopropylpyrimidin-2-yl]-N- methylmethansulfonamide Download PDFInfo
- Publication number
- SK284027B6 SK284027B6 SK332-2000A SK3322000A SK284027B6 SK 284027 B6 SK284027 B6 SK 284027B6 SK 3322000 A SK3322000 A SK 3322000A SK 284027 B6 SK284027 B6 SK 284027B6
- Authority
- SK
- Slovakia
- Prior art keywords
- fluorophenyl
- mmol
- isopropylpyrimidin
- chlorodiphenylphosphine
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- 238000002360 preparation method Methods 0.000 title claims description 4
- CVRDGWDBQZPJJI-UHFFFAOYSA-N n-[5-(diphenylphosphorylmethyl)-4-(4-fluorophenyl)-6-propan-2-ylpyrimidin-2-yl]-n-methylmethanesulfonamide Chemical compound C=1C=CC=CC=1P(=O)(C=1C=CC=CC=1)CC=1C(C(C)C)=NC(N(C)S(C)(=O)=O)=NC=1C1=CC=C(F)C=C1 CVRDGWDBQZPJJI-UHFFFAOYSA-N 0.000 title abstract description 21
- XGRJZXREYAXTGV-UHFFFAOYSA-N chlorodiphenylphosphine Chemical compound C=1C=CC=CC=1P(Cl)C1=CC=CC=C1 XGRJZXREYAXTGV-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 13
- 239000002585 base Substances 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 230000005595 deprotonation Effects 0.000 claims description 5
- 238000010537 deprotonation reaction Methods 0.000 claims description 5
- 229910001516 alkali metal iodide Inorganic materials 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 3
- 239000003444 phase transfer catalyst Substances 0.000 claims description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 150000001350 alkyl halides Chemical class 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 claims 1
- 150000008046 alkali metal hydrides Chemical class 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 75
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 20
- 239000007787 solid Substances 0.000 description 18
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Inorganic materials [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000001816 cooling Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 12
- MSDYDUNHTAYBHV-UHFFFAOYSA-N n-[4-(4-fluorophenyl)-5-(hydroxymethyl)-6-propan-2-ylpyrimidin-2-yl]-n-methylmethanesulfonamide Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1CO MSDYDUNHTAYBHV-UHFFFAOYSA-N 0.000 description 11
- 239000012074 organic phase Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000009518 sodium iodide Nutrition 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 3
- 238000009835 boiling Methods 0.000 description 2
- -1 diphenylphosphinoyl-methyl Chemical group 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 2
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- ZCRZCMUDOWDGOB-UHFFFAOYSA-N ethanesulfonimidic acid Chemical compound CCS(N)(=O)=O ZCRZCMUDOWDGOB-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- NNBZCPXTIHJBJL-MGCOHNPYSA-N trans-decalin Chemical compound C1CCC[C@@H]2CCCC[C@H]21 NNBZCPXTIHJBJL-MGCOHNPYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Oblasť technikyTechnical field
Predložený vynález sa týka spôsobu výroby N-[5-(difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu.The present invention relates to a process for the preparation of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide.
Doterajší stav technikyBACKGROUND OF THE INVENTION
N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamid je medziprodukt na výrobu farmaceutický účinných látok, napríklad inhibítorov HMG-Co A reduktázy (Bioorg. Med. Chem. 1997, 5, 437).N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide is an intermediate for the manufacture of pharmaceutical active substances, for example HMG-Co A reductase inhibitors (Bioorg. Med. Chem. Chem. 1997, 5, 437).
Úlohou predloženého vynálezu je nájsť zlepšenú dostupnosť uvedeného medziproduktu.It is an object of the present invention to find improved availability of said intermediate.
Úloha sa mohla vyriešiť novým spôsobom podľa patentového nároku 1.The object could be solved in a novel way according to claim 1.
Významnou výhodou syntézy podľa vynálezu je jej použiteľnosť vo veľkovýrobe.An important advantage of the synthesis according to the invention is its applicability in mass production.
Podstata vynálezuSUMMARY OF THE INVENTION
Podľa vynálezu sa výroba N-[5-(difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vzorca (I)According to the invention, the preparation of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide of formula (I)
uskutočňuje reakciou [4-(4-fluórfenyl)-6-izopropyl-2-(N· -metyl-N-metylsulfonyl-aminopyrimidin-5-yl]metanolu vzorca (II)by reacting [4- (4-fluorophenyl) -6-isopropyl-2- (N -methyl-N-methylsulfonylaminopyrimidin-5-yl) methanol of formula (II)
s chlórdifenylfosfínom.with chlorodiphenylphosphine.
[4-(4-Fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonyl-aminopyrimidin-5-yl]metanol vzorca (II) je možné jednoducho získať redukciou zodpovedajúceho esteru s napr. di-izobutylaiummiumhydridom(EP-A- 0521471).[4- (4-Fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino-pyrimidin-5-yl) methanol of formula (II) can be readily obtained by reduction of the corresponding ester with e.g. di-isobutylalium hydride (EP) -A- 0521471).
Reakcia [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylaminopyrimidin-5-yl]metanolu vzorca (II) s chlórdifenylfosfínom sa môže uskutočňovať buď priamo alebo predchádzajúcou deprotonizáciou. Výhodná je priama reakcia s chlórdifenylfosfínom a následným ošetrením so zásadou.The reaction of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylaminopyrimidin-5-yl) methanol of formula (II) with chlorodiphenylphosphine can be carried out either directly or by prior deprotonation. with chlorodiphenylphosphine and subsequent treatment with a base.
Podľa variantu „deprotonizácie“ sa [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metyl-sulfonyl-aminopyrirmdin-5-yl]metanol vzorca (II) účelne zmieša s deprotonizačným činidlom bežným v odbore, výhodne s hydridom alkalického kovu alebo hexaalkyldisilazánom alkalického kovu. Výhodne sa použije hydrid sodný. Zvyčajne sa deprotonizácia uskutočňuje pri teplote miestnosti. Potom nasleduje reakcia s chlórdifenylfosfínom. Reakcia s chlórdifenylfosfínom sa účelne uskutočňuje pri teplote medzi 80 a 200 °C.According to the "deprotonation" variant, [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylaminopyrrolidin-5-yl) methanol of formula (II) is conveniently mixed with a deprotonating agent customary in the art. Preferably, sodium hydride is used, usually deprotonation is carried out at room temperature, followed by reaction with chlorodiphenylphosphine The reaction with chlorodiphenylphosphine is conveniently carried out at a temperature between 80 and 200 ° C.
Chlórdifenylfosfín môže priamo slúžiť ako rozpúšťadlo. Je však možné použiť ako prídavok, pokiaľ je to možné, vysokovriace inertné rozpúšťadlo, ako napr. toluén alebo xylén alebo dekalin, rovnako ako príslušné izoméme zmesi.Chlorodiphenylphosphine can directly serve as a solvent. However, it is possible to use, as far as possible, a high boiling inert solvent such as e.g. toluene or xylene or decalin, as well as the corresponding isomeric mixtures.
Reakcia sa môže uskutočňovať za prítomnosti katalyzátora. Ako katalyzátor je vhodný jód, jodid alkalického kovu, ako napr. jodid sodný alebo draselný, alkylhalogenid ako napr. metyl- alebo etyljodid, alebo dihalogénalkán ako napr. dibrómmetán. Výhodne sa používa jodid alkalického kovu. Množstvo katalyzátora sa zvyčajne zvolí v rozmedzí 1 mol % až 20 mol %, vztiahnuté na použitý alkohol vzorca (II).The reaction may be carried out in the presence of a catalyst. Suitable catalysts are iodine, an alkali metal iodide, such as e.g. sodium or potassium iodide, an alkyl halide such as e.g. methyl or ethyl iodide, or dihaloalkane such as e.g. dibromomethane. Preferably, an alkali metal iodide is used. The amount of catalyst is usually chosen in the range from 1 mol% to 20 mol%, based on the alcohol of formula (II) used.
Reakcia podľa priameho variantu sa uskutočňuje účelne pri teplote od -20 do 130 °C, výhodne pri +20 až 120 °C.The reaction according to the direct variant is conveniently carried out at a temperature of from -20 to 130 ° C, preferably at +20 to 120 ° C.
Chlórdifenylfosfín môže pri variante „deprotonizácie“ priamo slúžiť ako rozpúšťadlo. Je však možné použiť ako prídavok, pokiaľ je to možné, vysokovriace inertné rozpúšťadlo, ako napr. toluén alebo xylén alebo dekalin, rovnako ako príslušné izoméme zmesi.Chlorodiphenylphosphine can directly serve as a solvent in the "deprotonation" variant. However, it is possible to use, as far as possible, a high boiling inert solvent such as e.g. toluene or xylene or decalin, as well as the corresponding isomeric mixtures.
V nadväznosti na reakciu s chlórdifenylfosfínom sa reakčná zmes zmieša so zásadou. Vhodné zásady sú hydroxidy alkalických kovov, ako napr. vodný roztok hydroxidu sodného alebo draselného alebo uhličitany alkalických kovov, ako napr. uhličitan sodný alebo draselný.Following the reaction with chlorodiphenylphosphine, the reaction mixture is mixed with a base. Suitable bases are alkali metal hydroxides such as e.g. aqueous sodium or potassium hydroxide solution or alkali metal carbonates such as e.g. sodium or potassium carbonate.
Prípadne sa na urýchlenie reakcie so zásadou môže použiť zvyčajný fázovotransférový katalyzátor, ako napr. tetraalkylamóniumhalogenid. Dobré výsledky je možné dosiahnuť tiež použitím korunových éterov.Optionally, a conventional phase-transfer catalyst such as e.g. tetraalkylammonium. Good results can also be achieved by using crown ethers.
N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamid vzorca (I) sa môže po skončení reakcie izolovať v odbore známym spôsobom, napr. extrakciou vhodným rozpúšťadlom z reakčnej zmesi rovnako ako kryštalizáciou zo zmesi.N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide of formula (I) may be isolated in a manner known in the art, e.g. extraction with a suitable solvent from the reaction mixture as well as crystallization from the mixture.
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Príklad 1 N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl] -N-metyl-metánsulfonamidExample 1 N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
1,00 g (2,83 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonyl-amino)-pyrimidin-5-yl]metanolu sa pridalo k 5 ml cis/trans-dekalínu a zmiešalo s 204 mg (4,68 mmol) hydridu sodného (55 % disperzie v minerálnom oleji). Po 30 min. pri teplote miestnosti sa za silného miešania pridalo v priebehu 6 min. 680 mg (2,93 mmol) chlórdifenylfosfínu. Primiešalo sa 52,2 mg (0,35 mmol) jodidu sodného a zahrievalo sa počas 2 hodín 15 minút na 184 - 186 °C. Po ochladení na teplotu miestnosti sa primiešalo 50 ml 38 - 40 % roztoku hydrogensulfitu sodného a 50 ml etylesteru kyseliny octovej. Organická fáza sa oddelila a vodná fáza sa extrahovala s 50 ml etylesteru kyseliny octovej. Spojené organické fázy sa sušili nad síranom horečnatým a vákuovo zahustili. Získalo sa 1,74 g surového produktu, ktorý sa čistil chromatograficky na silikagéli (premývací prostriedok: n-hexán/etylester kyseliny octovej 1 : 2). Získalo sa 382,4 mg (25,1 %) N-[5-(difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky. (Teplota topenia 184 - 185 °C).1.00 g (2.83 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 5 mL of cis % trans-decalin and mixed with 204 mg (4.68 mmol) of sodium hydride (55% dispersion in mineral oil). After 30 min. at room temperature was added with vigorous stirring over 6 min. 680 mg (2.93 mmol) of chlorodiphenylphosphine. 52.2 mg (0.35 mmol) of sodium iodide was added and heated at 184-186 ° C for 2 hours 15 minutes. After cooling to room temperature, 50 ml of a 38-40% sodium hydrogensulfite solution and 50 ml of ethyl acetate were mixed. The organic phase was separated and the aqueous phase was extracted with 50 ml of ethyl acetate. The combined organic phases were dried over magnesium sulfate and concentrated in vacuo. 1.74 g of crude product were obtained, which was purified by chromatography on silica gel (eluent: n-hexane / ethyl acetate 1: 2). 382.4 mg (25.1%) of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide was obtained as a colorless solid. (Mp 184-185 ° C).
'H NMR (DMSO-d6,400 MHz): δ = 1,11 (d, J = 6,6 Hz, 6H; 3,28 (sept, J=6,6 Hz, IH); 3,40 (s, 3H);1 H NMR (DMSO-d 6 , 400 MHz): δ = 1.11 (d, J = 6.6 Hz, 6H; 3.28 (sept, J = 6.6 Hz, 1H); 3.40 ( s, 3H);
3,51 (s,3H); 4,05 (d, J =12,6 Hz, 2H); 7,07 (t, J = 8,9 Hz, 2H); 7,35 (m, 2H);3.51 (s, 3H); 4.05 (d, J = 12.6Hz, 2H); 7.07 (t, J = 8.9Hz, 2H); 7.35 (m. 2H);
7,42 (m, 4H); 7,5-7,9 (m, 6H).7.42 (m, 4H); 7.5-7.9 (m, 6H).
,3C NMR (DMSO-d6, 100 MHz): δ = 21,52 (q); 13 C NMR (DMSO-d 6 , 100 MHz): δ = 21.52 (q);
29,12 (td);29.12 (td);
31,94 (d); 33,07 (q);31.94 (d); 33.07 (q);
41,53 (q);41.53 (q);
114.50 (sd); 115,03 (dd);114.50 (sd); 115.03 (dd);
128.54 (dd); 130,21 (dd); 130,84 (dd); 131,64 (dd); 133,41 (sd);128.54 (dd); 130.21 (dd); 130.84 (dd); 131.64 (dd); 133.41 (sd);
134.51 (sd);134.51 (sd);
156.54 (sd); 162,10 (sd); 165,86 (sd); 176,49 (sd).156.54 (sd); 162.10 (sd); 165.86 (sd); 176.49 (sd).
Príklad 2 N-[5-(Difenylfosfmoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidExample 2 N- [5- (Diphenylphosphmoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
282,8 mg (0,80 mmol) [4-(4-íluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 4,5 ml xylénu (izoméma zmes) a zmiešalo s 55 mg (1,30 mmol) hydridu sodného (55 % disperzie v minerálnom oleji). Po 35 min. pri teplote miestnosti sa za silného miešania pridalo v priebehu 5 min. 185 mg (0,84 mmol) chlórdifenylfosímu v 1,5 ml xylénu a potom sa 20 hod. zahrievalo na 135 °C. Po ochladení na teplotu miestnosti sa primiešalo 15 ml vody a extrahovalo sa 10 ml etylesteru kyseliny octovej. Organická fáza sa oddelila a vodná fáza sa extrahovala s 2 x 10 ml etylesteru kyseliny octovej. Spojené organické fázy sušili (MgSO4) a vákuovo zahustili. Získalo sa 510 mg surového produktu, ktorý sa čistil chromatograficky na silikagéli (premývací prostriedok: n-hexán/etylester kyseliny octovej 1 : 2, potom etylester kyseliny octovej). Izolovalo sa 230 mg (53,5 %) N-[5-(difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.282.8 mg (0.80 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 4.5 mL of xylene (isomeric mixture) and mixed with 55 mg (1.30 mmol) of sodium hydride (55% dispersion in mineral oil). After 35 min. at room temperature was added over 5 min with vigorous stirring. 185 mg (0.84 mmol) of chlorodiphenylphosphine in 1.5 ml of xylene and then 20 h. heated to 135 ° C. After cooling to room temperature, 15 ml of water were added and extracted with 10 ml of ethyl acetate. The organic phase was separated and the aqueous phase was extracted with 2 x 10 ml ethyl acetate. The combined organics were dried (MgSO4) and concentrated in vacuo. 510 mg of crude product was obtained, which was purified by chromatography on silica gel (eluent: n-hexane / ethyl acetate 1: 2, then ethyl acetate). 230 mg (53.5%) of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide was isolated as a colorless solid.
Príklad 3 N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidExample 3 N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
512 mg (1,45 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 8 ml toluénu a zmiešalo s 96 mg (2,20 mmol) hydridu sodného (55 % disperzie v minerálnom oleji). Po 1 hod. pri teplote miestnosti sa za silného miešania pridalo v priebehu 5 min. 333,5 mg (1,44 mmol) chlórdifenylfosfínu v 2,5 ml toluénu. Primiešalo sa 28,7 mg (0,19 mmol) jodidu sodného a zahrievalo sa počas 22 hod na 108 °C. Po 6 hod. sa zmiešalo s ďalšími 28,7 mg (0,19 mmol) jodidu sodného. Po ochladení na teplotu miestnosti sa primiešalo 30 ml 38 - 40 % roztoku hydrogensulfitu sodného a extrahovalo sa 50 ml etylesteru kyseliny octovej. Organická fáza sa oddelila a vodná fáza sa extrahovala s 50 ml etylesteru kyseliny octovej. Spojené organické fázy sa vákuovo za hustili. Získalo sa 740 mg surového produktu, ktorý sa čistil chromatograficky na silikagéli (premývací prostriedok: etylester kyseliny octovej), a izolovalo sa 212,7 mg (27,3 %) N-[5-(difenylfosfinoyl-metyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.512 mg (1.45 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 8 mL of toluene and mixed with 96 mL mg (2.20 mmol) of sodium hydride (55% dispersion in mineral oil). After 1 hour at room temperature was added over 5 min with vigorous stirring. 333.5 mg (1.44 mmol) of chlorodiphenylphosphine in 2.5 ml of toluene. Sodium iodide (28.7 mg, 0.19 mmol) was admixed and heated to 108 ° C for 22 h. After 6 hours was mixed with an additional 28.7 mg (0.19 mmol) of sodium iodide. After cooling to room temperature, 30 ml of 38-40% sodium hydrogen sulphite solution were admixed and extracted with 50 ml of ethyl acetate. The organic phase was separated and the aqueous phase was extracted with 50 ml of ethyl acetate. The combined organic phases were vacuum vacuumed. 740 mg of a crude product was obtained, which was purified by chromatography on silica gel (eluent: ethyl acetate), and 212.7 mg (27.3%) of N- [5- (diphenylphosphinoyl-methyl) -4- (4-methyl-4-methoxyphenyl) was isolated. (fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide as a colorless solid.
Príklad 4 N-[5-(Difcnylfosfmoylmctyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidExample 4 N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
502,6 mg (1,42 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 8 ml xylénu (izoméma zmes) a zmiešalo s502.6 mg (1.42 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 8 mL of xylene (isomeric) mixture) and mixed with
96.6 mg (2,21 mmol) hydridu sodného (55 % disperzie v minerálnom oleji). Po 1 hod. pri teplote miestnosti sa za silného miešania pridalo v priebehu 5 min. 340,8 mg (1,47 mmol) chlórdifenylfosímu v 2,5 ml xylénu. Primiešalo sa 34,6 mg (0,23 mmol) jodidu sodného a zahrievalo sa 19 hod. pri 136 °C. Po 3 hod. sa zmiešalo s ďalšími 25,1 mg jodidu sodného. Po ochladení na teplotu miestnosti sa primiešalo 30 ml zriedeného roztoku hydrogensulfitu sodného a extrahovalo sa 50 ml etylesteru kyseliny octovej. Organická fáza sa oddelila a vodná fáza sa extrahovala 50 ml etylesteru kyseliny octovej. Spojené organické fázy sa vákuovo zahustili. Získalo sa 906 mg surového produktu, ktorý sa čistil chromatograficky na silikagéli (premývací prostriedok: etylester kyseliny octovej). Izolovalo sa 315,9 mg (41,3 %) N-[5-(difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.96.6 mg (2.21 mmol) of sodium hydride (55% dispersion in mineral oil). After 1 hour at room temperature was added over 5 min with vigorous stirring. 340.8 mg (1.47 mmol) of chlorodiphenylphosphine in 2.5 ml of xylene. Sodium iodide (34.6 mg, 0.23 mmol) was admixed and heated for 19 h. at 136 ° C. After 3 hours was mixed with another 25.1 mg of sodium iodide. After cooling to room temperature, 30 ml of dilute sodium hydrogen sulphite solution were added and extracted with 50 ml of ethyl acetate. The organic phase was separated and the aqueous phase was extracted with 50 ml of ethyl acetate. The combined organic phases were concentrated in vacuo. 906 mg of crude product was obtained, which was purified by chromatography on silica gel (eluent: ethyl acetate). 315.9 mg (41.3%) of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide was isolated as a colorless solid.
Príklad 5 (priama reakcia) N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidExample 5 (direct reaction) N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
1,05 mg (2,95 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 7 g toluénu za chladenia v ľadovom kúpeli a za miešania sa zmiešalo s 820 mg (3,69 mmol) chlórdifenylfosfínu. Zahrievalo sa 3 hod. na 108 °C. Po ochladení na teplotu miestnosti sa primiešalo 553 mg (4,43 mmol) vodného roztoku hydroxidu draselného (45 %) a 97,5 mg (0,29 mmol) tetrabutylamóniumbromidu a pri 60 °C sa 1 hod. silne miešalo. Zdroj tepla sa odstránil a ešte teplá reakčná zmes sa zmiešala s 20 ml vody. Zmes sa nechala pomaly ochladiť na 4 °C a vyzrážaná pevná látka sa odfiltrovala. Produkt sa premyl studenou vodou a toluénom a sušil vo vákuu pri 40 °C. Izolovalo sa 1,04 g (64,1 %; obsah:1.05 mg (2.95 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 7 g of toluene with cooling in an ice bath and stirred with 820 mg (3.69 mmol) of chlorodiphenylphosphine. Heat for 3 hours. to 108 ° C. After cooling to room temperature, 553 mg (4.43 mmol) of aqueous potassium hydroxide solution (45%) and 97.5 mg (0.29 mmol) of tetrabutylammonium bromide were admixed and stirred at 60 ° C for 1 hour. stirred vigorously. The heat source was removed and the still warm reaction mixture was mixed with 20 ml of water. The mixture was allowed to cool slowly to 4 ° C and the precipitated solid was filtered off. The product was washed with cold water and toluene and dried under vacuum at 40 ° C. 1.04 g (64.1%) was isolated;
97.6 %) N-[5-(difenylfosfinoyl-metyl)-4-(4-íluórfenyl)-6-izopropylpyrimidin-2-yl] -N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.97.6%) N- [5- (diphenylphosphinoyl-methyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide as a colorless solid.
Príklad 6 (priama reakcia) N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidExample 6 (direct reaction) N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
2,03 mg (5,69 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 13 g toluénu a za chladenia v ľadovom kúpeli sa zmiešalo s 1,67 g (7,51 mmol) chlórdifenylfosfínu v 2 g toluénu. Zahrievalo sa 2,5 hod na 111 °C. Po ochladení na teplotu miestnosti sa primiešalo 1,08 g (8,66 mmol) 45 % hydroxidu draselného a 175 mg (0,574 mmol) tetrabutylamóniumbromidu a pri 60 °C sa 2 hod. silne miešalo. K teplej reakčnej zmesi sa pridalo 30 ml vody. Zmes sa krátko miešala pri 60 °C, nechala sa pomaly ochladiť na 4 °C a vyzrážaná pevná látka sa odfiltrovala. Produkt sa premyl studenou vodou (10 ml) a studeným toluénom (10 ml) a sušil vo vákuu pri 40 °C. Izolovalo sa 2,66 g (84,1 %; obsah: 96,6 %) N-[5-(difenyl-fosfmoyl-metyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.2.03 mg (5.69 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 13 g of toluene and Cooling in an ice bath was mixed with 1.67 g (7.51 mmol) of chlorodiphenylphosphine in 2 g of toluene. It was heated at 111 ° C for 2.5 hours. After cooling to room temperature, 1.08 g (8.66 mmol) of 45% potassium hydroxide and 175 mg (0.574 mmol) of tetrabutylammonium bromide were admixed and stirred at 60 ° C for 2 hours. stirred vigorously. To the warm reaction mixture was added 30 mL of water. The mixture was stirred briefly at 60 ° C, allowed to slowly cool to 4 ° C and the precipitated solid was filtered off. The product was washed with cold water (10 mL) and cold toluene (10 mL) and dried under vacuum at 40 ° C. 2.66 g (84.1%; content: 96.6%) of N- [5- (diphenylphosphmoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N were isolated. methyl methanesulfonamide as a colorless solid.
Príklad 7 (priama reakcia) N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-rnetánsulfonamidExample 7 (direct reaction) N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
2,02 mg (5,69 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 13,1 g toluénu a za chladenia v ľadovom kúpeli sa zmiešalo s 1,67 g (7,51 mmol) chlórdifenylfosflnu v2.02 mg (5.69 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 13.1 g of toluene and with cooling in an ice bath was mixed with 1.67 g (7.51 mmol) of chlorodiphenylphosphine in
1.9 g toluénu. Zahrievalo sa 3 hod. na 109 °C. Po ochladení na teplotu miestnosti sa primiešalo 590 mg (8,94 mmol) pevného hydroxidu draselného a 159 mg (0,582 mmol) 18-Crown-6 a pri 60 °C sa 3,5 hod. silne miešalo. K teplej reakčnej zmesi sa pridalo 30 ml vody. Zmes sa krátko miešala pri 60 °C, nechala sa pomaly ochladiť na 4 °C a vyzrážaná pevná látka sa odfiltrovala. Produkt sa premyl studenou vodou (10 ml) a studeným toluénom (10 ml) a sušil vo vákuu pri 40 °C. Izolovalo sa 1,82 g (59,5 %; obsah:1.9 g toluene. Heat for 3 hours. to 109 ° C. After cooling to room temperature, 590 mg (8.94 mmol) of solid potassium hydroxide and 159 mg (0.582 mmol) of 18-Crown-6 were admixed and stirred at 60 ° C for 3.5 hours. stirred vigorously. To the warm reaction mixture was added 30 mL of water. The mixture was stirred briefly at 60 ° C, allowed to slowly cool to 4 ° C and the precipitated solid was filtered off. The product was washed with cold water (10 mL) and cold toluene (10 mL) and dried under vacuum at 40 ° C. 1.82 g (59.5%) was isolated;
95.9 %) N-[5-(difenyl-fosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.95.9%) N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide as a colorless solid.
Príklad 8 (priama reakcia) N-[5-(Difenylfosfmoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidExample 8 (direct reaction) N- [5- (Diphenylphosphmoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
2,02 mg (5,69 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 13,1 g toluénu a za chladenia v ľadovom kúpeli sa zmiešalo s 1,71 g (7,69 mmol) chlórdifenylfosflnu v2.02 mg (5.69 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 13.1 g of toluene and mixed with 1.71 g (7.69 mmol) of chlorodiphenylphosphine in ice bath
1.9 g toluénu. Zahrievalo sa 2,5 hod na 111 °C. Po ochladení na teplotu miestnosti sa pridalo 1,17 g (8,78 mmol) 30 % hydroxidu draselného a 182 mg (0,597 mmol) tetrabutylamóniumchloridu a pri 60 °C sa 3,5 hod. silne miešalo. K teplej reakčnej zmesi sa pridalo 30 ml vody. Zmes sa krátko miešala pri 60 °C, nechala sa pomaly ochladiť na 4 °C a vyzrážaná pevná látka sa odfiltrovala. Produkt sa premyl studenou vodou (10 ml) a studeným toluénom (10 ml) a vákuovo sušil pri 40 °C. Izolovalo sa 2,18 g (71,3 %; obsah: 97,3 %) N-[5-(difenylfosfmoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky (teplota topenia 184 - 185 °C).1.9 g toluene. It was heated at 111 ° C for 2.5 hours. After cooling to room temperature, 1.17 g (8.78 mmol) of 30% potassium hydroxide and 182 mg (0.597 mmol) of tetrabutylammonium chloride were added thereto at 60 ° C for 3.5 hours. stirred vigorously. To the warm reaction mixture was added 30 mL of water. The mixture was stirred briefly at 60 ° C, allowed to slowly cool to 4 ° C and the precipitated solid was filtered off. The product was washed with cold water (10 mL) and cold toluene (10 mL) and vacuum dried at 40 ° C. 2.18 g (71.3%; content: 97.3%) of N- [5- (diphenylphosphmoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide was isolated as colorless solid (m.p. 184-185 ° C).
Príklad 9 (priama reakcia) N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidín-2-yl]-N-metyl-metánsulfonamidExample 9 (direct reaction) N- [5- (Diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
Suspenzia 9,29 g (26,3 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)pyrimidin-5-yl]metanolu v 26 g toluénu sa za chladenia v ľadovom kúpeli zmiešala so 7,64 g (34,4 mmol) chlórdifenylfosflnu. Premyla sa trochou toluénu a zahrievala 2 hod na 111 °C. Po ochladení na teplotu miestnosti sa primiešalo 4,94 g 45 % hydroxidu draselného a 873 mg (2,71 mmol) tetrabutylamóniumbromidu a pri 60 °C sa 1 hod. silne miešala. K teplej reakčnej zmesi sa pridalo 100 ml vody. Zmes sa krátko miešala pri 60 °C, nechala sa pomaly ochladiť na 4 °C a vyzrážaná pevná látka sa odfiltrovala. Produkt sa premyl studenou vodou (30 ml) a studeným toluénom a vákuovo sušil pri 40 °C. Izolovalo sa 11,74 g (78,4 %; obsah: 94,4 %) N-[5-(difenyl-fosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl] -N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.A suspension of 9.29 g (26.3 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) pyrimidin-5-yl] methanol in 26 g of toluene was cooled in It was mixed with 7.64 g (34.4 mmol) of chlorodiphenylphosphine in an ice bath. It was washed with a little toluene and heated at 111 ° C for 2 hours. After cooling to room temperature, 4.94 g of 45% potassium hydroxide and 873 mg (2.71 mmol) of tetrabutylammonium bromide were admixed and stirred at 60 ° C for 1 hour. stirred vigorously. To the warm reaction mixture was added 100 mL of water. The mixture was stirred briefly at 60 ° C, allowed to slowly cool to 4 ° C and the precipitated solid was filtered off. The product was washed with cold water (30 mL) and cold toluene and vacuum dried at 40 ° C. 11.74 g (78.4%; content: 94.4%) of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide were isolated. in the form of a colorless solid.
Príklad 10 (priama reakcia bez fázovotransférového katalyzátora)Example 10 (direct reaction without phase-transfer catalyst)
N-[5-(Difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidN- [5- (Difenylfosfinoylmetyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methyl-methanesulfonamide
2,03 g (5,69 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonylamino)-pyrimidin-5-yl]metanolu sa pridalo k 13 g toluénu a za chladenia v ľadovom kúpeli sa zmiešalo s 1,69 g (7,60 mmol) chlórdifenylfosflnu v 1,9 g toluénu. Zahrievalo sa 2,5 hod na 109 °C. Po ochladení na teplotu miestnosti sa primiešalo 1,09 g (8,74 mmol) 45 % hydroxidu draselného a pri 60 °C sa 2 hod. 45 min. silne miešalo. K teplej reakčnej zmesi sa pridalo 30 ml vody. Zmes sa krátko miešala pri 60 °C, nechala sa pomaly ochladiť na 4 °C a vyzrážaná pevná látka sa odfiltrovala. Produkt sa premyl studenou vodou (10 ml) a studeným toluénom (10 ml) a vákuovo sušil pri 40 °C. Izolovalo sa 2,44 g (76,8 %; obsah: 99,1 %) N-[5-(difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky.2.03 g (5.69 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) -pyrimidin-5-yl] methanol was added to 13 g of toluene and Cooling in an ice bath was mixed with 1.69 g (7.60 mmol) of chlorodiphenylphosphine in 1.9 g of toluene. It was heated at 109 ° C for 2.5 hours. After cooling to room temperature, 1.09 g (8.74 mmol) of 45% potassium hydroxide was admixed and stirred at 60 ° C for 2 hours. 45 min. stirred vigorously. To the warm reaction mixture was added 30 mL of water. The mixture was stirred briefly at 60 ° C, allowed to slowly cool to 4 ° C and the precipitated solid was filtered off. The product was washed with cold water (10 mL) and cold toluene (10 mL) and vacuum dried at 40 ° C. 2.44 g (76.8%; content: 99.1%) of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide was isolated as colorless solid.
Príklad 11 (priama reakcia) N-[5-(Difenylfosfmoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metyl-metánsulfonamidExample 11 (direct reaction) N- [5- (Diphenylphosphmoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide
Roztok 60,08 g (0,170 mmol) [4-(4-fluórfenyl)-6-izopropyl-2-(N-metyl-N-metylsulfonyl-amino)pyrimidin-5-yljmetanolu v cca 485 ml toluénu sa zmiešal pri 60 °C so 42,55 g (0,192 mol; obsah 99,7 %) chlórdifenylfosflnu. Nechalo sa to 2,5 hod. miešať a tento roztok sa pridal na zmes 60 °C teplú zo 70,66 g hydroxidu draselného (20 %) a 5,04 g (0,017 mol) tetrabutylamóniumchloridu a premylo sa 13 ml toluénu. Miešalo sa to 2 hod. pri 60 °C a pridalo sa 215 ml vody a 108 ml toluénu. Pri cca 80 °C sa vodná fáza oddelila a organická fáza sa ešte dvakrát extrahovala zakaždým s 215 ml horúcej vody. Potom sa azeotropicky odvodnilo na odvodňovacom zariadení a nechalo sa počas 2 hod. ochladiť na 0 °C. Vzniknuté kryštály sa odfiltrovali a dvakrát premyli 160 ml toluénu. Po vákuovom sušení pri 40 °C sa získalo 81,94 g (89,7 %) N-[5-(difenylfosfinoylmetyl)-4-(4-fluórfenyl)-6-izopropylpyrimidin-2-yl]-N-metylmetánsulfonamidu vo forme bezfarebnej pevnej látky [obsah (podľa HPLC): 100 %].A solution of 60.08 g (0.170 mmol) of [4- (4-fluorophenyl) -6-isopropyl-2- (N-methyl-N-methylsulfonylamino) pyrimidin-5-yl] -methanol in ca. 485 ml of toluene was mixed at 60 ° C with 42.55 g (0.192 mol; 99.7% content) of chlorodiphenylphosphine. It was left for 2.5 hours. This solution was added to a 60 ° C mixture of 70.66 g of potassium hydroxide (20%) and 5.04 g (0.017 mol) of tetrabutylammonium chloride and washed with 13 ml of toluene. It was stirred for 2 hours. at 60 ° C and 215 ml of water and 108 ml of toluene were added. At about 80 ° C, the aqueous phase was separated and the organic phase was extracted twice more with 215 ml of hot water each time. It was then azeotropically dewatered on a dewatering device and left for 2 hours. cool to 0 ° C. The resulting crystals were filtered off and washed twice with 160 ml of toluene. After vacuum drying at 40 ° C, 81.94 g (89.7%) of N- [5- (diphenylphosphinoylmethyl) -4- (4-fluorophenyl) -6-isopropylpyrimidin-2-yl] -N-methylmethanesulfonamide was obtained in the form of colorless solid [HPLC content: 100%].
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99104786 | 1999-03-10 | ||
EP99104785 | 1999-03-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
SK3322000A3 SK3322000A3 (en) | 2000-10-09 |
SK284027B6 true SK284027B6 (en) | 2004-08-03 |
Family
ID=26152921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK332-2000A SK284027B6 (en) | 1999-03-10 | 2000-03-07 | Process for the preparation of N-[5-(diphenylphosphinoylmethyl)- 4-(4-fluorphenyl)-6-isopropylpyrimidin-2-yl]-N- methylmethansulfonamide |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1035127B1 (en) |
JP (1) | JP4438167B2 (en) |
KR (1) | KR100586664B1 (en) |
CN (1) | CN1126755C (en) |
AT (1) | ATE251633T1 (en) |
CA (1) | CA2300243C (en) |
CZ (1) | CZ298235B6 (en) |
DE (1) | DE50003959D1 (en) |
DK (1) | DK1035127T3 (en) |
ES (1) | ES2208167T3 (en) |
HK (1) | HK1029996A1 (en) |
HU (1) | HU224967B1 (en) |
NO (1) | NO324982B1 (en) |
PL (1) | PL195166B1 (en) |
PT (1) | PT1035127E (en) |
SK (1) | SK284027B6 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0311195A (en) * | 2002-05-21 | 2005-02-22 | Ranbaxy Lab Ltd | Rosuvastatin Preparation Process |
US7341743B2 (en) | 2004-10-28 | 2008-03-11 | Revlon Consumer Products Corporation | Color cosmetic compositions |
CA2725052C (en) | 2008-05-27 | 2014-09-16 | Changzhou Pharmaceutical Factory Co., Ltd. | Preparation method of rosuvastatin calcium and its intermediates |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2648897B2 (en) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | Pyrimidine derivatives |
-
2000
- 2000-03-07 CZ CZ20000837A patent/CZ298235B6/en not_active IP Right Cessation
- 2000-03-07 SK SK332-2000A patent/SK284027B6/en not_active IP Right Cessation
- 2000-03-09 DK DK00105011T patent/DK1035127T3/en active
- 2000-03-09 DE DE50003959T patent/DE50003959D1/en not_active Expired - Lifetime
- 2000-03-09 CA CA002300243A patent/CA2300243C/en not_active Expired - Lifetime
- 2000-03-09 ES ES00105011T patent/ES2208167T3/en not_active Expired - Lifetime
- 2000-03-09 EP EP00105011A patent/EP1035127B1/en not_active Expired - Lifetime
- 2000-03-09 NO NO20001228A patent/NO324982B1/en not_active IP Right Cessation
- 2000-03-09 PT PT00105011T patent/PT1035127E/en unknown
- 2000-03-09 AT AT00105011T patent/ATE251633T1/en active
- 2000-03-10 CN CN00103783A patent/CN1126755C/en not_active Expired - Lifetime
- 2000-03-10 KR KR1020000012002A patent/KR100586664B1/en not_active IP Right Cessation
- 2000-03-10 PL PL338944A patent/PL195166B1/en unknown
- 2000-03-10 HU HU0001127A patent/HU224967B1/en unknown
- 2000-03-10 JP JP2000066084A patent/JP4438167B2/en not_active Expired - Lifetime
-
2001
- 2001-02-08 HK HK01100875A patent/HK1029996A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK1035127T3 (en) | 2003-11-03 |
CN1272499A (en) | 2000-11-08 |
HK1029996A1 (en) | 2001-04-20 |
PL338944A1 (en) | 2000-09-11 |
JP2000309595A (en) | 2000-11-07 |
CZ298235B6 (en) | 2007-08-01 |
EP1035127B1 (en) | 2003-10-08 |
NO20001228L (en) | 2000-09-11 |
CN1126755C (en) | 2003-11-05 |
JP4438167B2 (en) | 2010-03-24 |
PT1035127E (en) | 2004-02-27 |
NO20001228D0 (en) | 2000-03-09 |
SK3322000A3 (en) | 2000-10-09 |
ES2208167T3 (en) | 2004-06-16 |
NO324982B1 (en) | 2008-01-14 |
KR100586664B1 (en) | 2006-06-07 |
HUP0001127A3 (en) | 2003-07-28 |
KR20010006773A (en) | 2001-01-26 |
EP1035127A1 (en) | 2000-09-13 |
DE50003959D1 (en) | 2003-11-13 |
PL195166B1 (en) | 2007-08-31 |
ATE251633T1 (en) | 2003-10-15 |
CA2300243A1 (en) | 2000-09-10 |
HU0001127D0 (en) | 2000-05-28 |
HU224967B1 (en) | 2006-04-28 |
CA2300243C (en) | 2009-12-29 |
HUP0001127A2 (en) | 2001-06-28 |
CZ2000837A3 (en) | 2000-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002318041B2 (en) | Preparation of aminopyrimidine compounds | |
WO2006067456A2 (en) | Process for preparing rosuvastatin | |
WO2006076845A1 (en) | Process for producing rosuvastatin calcium, intermediate for the preparation of the same and process for producing the intermediate | |
TW425383B (en) | Novel Α-hydroxyl acid derivatives, their preparation and use | |
WO2008072078A1 (en) | An improved process for preparing rosuvastatin caclium | |
WO2010038124A1 (en) | An improved process for preparing pyrimidine propenaldehyde | |
JP4649813B2 (en) | Process for producing 2-amino-4- (4-fluorophenyl) -6-alkylpyrimidine-5-carboxylate | |
JPH10139765A (en) | Production of pyrimidine derivative | |
SK284027B6 (en) | Process for the preparation of N-[5-(diphenylphosphinoylmethyl)- 4-(4-fluorphenyl)-6-isopropylpyrimidin-2-yl]-N- methylmethansulfonamide | |
US6160115A (en) | Process for preparing N-[5-(diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin -2-yl]-N-methylmethanesulfonamide | |
JP4501015B2 (en) | Method for producing aminopyrimidine compound | |
US6734303B2 (en) | Process for the production of quinazolines | |
CA2359958C (en) | Process for preparing 1-(6-methylpyridin-3yl)-2-[(4-methylsulfonyl)phenyl]ethanone | |
JP2003520762A (en) | Preparation of thiobarbituric acid derivatives | |
JP4123609B2 (en) | Process for producing 6- (α-fluoroalkyl) -4-pyrimidone | |
JP2003506311A (en) | Method for producing toluenesulfinate | |
JPH05112535A (en) | Process for manufacturing 4-amino-2-chloro-5-cyano-6- (methylthio)pyrimidine | |
HU196222B (en) | Process for producing 5-substituted 3',5',-diacyl-2'-deoxy-uridines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiry of patent |
Expiry date: 20200307 |